Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Crescita Therapeutics Inc T.CTX

Alternate Symbol(s):  CRRTF

Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. It also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.


TSX:CTX - Post by User

Bullboard Posts
Comment by FrozenInOntarioon Jul 16, 2019 1:52pm
61 Views
Post# 29925928

RE:RE:Extended patent protection for Pliagis

RE:RE:Extended patent protection for PliagisWhile geographic expansion is interesting, expansion of Pliagis usage in the States can bring increasing royalties.
Made very good money with Cynosure where growth was driven by their tatoo removal business.   Most of their competitors were bought out also.  So much tattoo regrets and so many poeple with tattoos.   Was always amazed to see pictures and comments of patients talking about the pain when they were getting lasered.   5 -10 treatments required.  You can check out interesting pictures on Realself.
So that business is booming in the States and they have the perfect treatment to limit and control pain.
Seems like a no brainer to me.   Market is huge...  And with the not for home use label taken off, just cannot wait  to see what type of royalties increase (pure profit) we can get.  3.50 might prove conservative.

GLTA
Bullboard Posts